4-Chloroloratadine
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 599228

CAS#: 165739-83-3

Description: 4-Chloroloratadine is an impurity of Loratadine.


Chemical Structure

img
4-Chloroloratadine
CAS# 165739-83-3

Theoretical Analysis

MedKoo Cat#: 599228
Name: 4-Chloroloratadine
CAS#: 165739-83-3
Chemical Formula: C22H22Cl2N2O2
Exact Mass: 416.1058
Molecular Weight: 417.33
Elemental Analysis: C, 63.32; H, 5.31; Cl, 16.99; N, 6.71; O, 7.67

Price and Availability

Size Price Availability Quantity
1.0mg USD 400.0 2 Weeks
100.0mg USD 2090.0 2 Weeks
Bulk inquiry

Synonym: 4-Chloroloratadine; 4-Chloro loratadine; Loratadine specified impurity C;

IUPAC/Chemical Name: ethyl 4-(4,8-dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate

InChi Key: LOTMYBFPXGPIDD-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H22Cl2N2O2/c1-2-28-22(27)26-11-8-14(9-12-26)20-17-6-4-16(23)13-15(17)3-5-18-19(24)7-10-25-21(18)20/h4,6-7,10,13H,2-3,5,8-9,11-12H2,1H3

SMILES Code: O=C(N1CC/C(CC1)=C2C3=CC=C(Cl)C=C3CCC4=C(Cl)C=CN=C4\2)OCC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Preparing Stock Solutions

The following data is based on the product molecular weight 417.33 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Abd el-HS, Colyer CL, Hassan WS, Shalaby A. Utility of 4-chloro-7-nitrobenzofurazan (NBD-CI) for the Spectrophotometric and spectrofluorometric determination of several antihistamine and antihypertensive drugs. J AOAC Int. 2013 Sep-Oct;96(5):968-75. PubMed PMID: 24282933.

2: Parkinson A, Clement RP, Casciano CN, Cayen MN. Evaluation of loratadine as an inducer of liver microsomal cytochrome P450 in rats and mice. Biochem Pharmacol. 1992 May 28;43(10):2169-80. PubMed PMID: 1534660.

3: Reddy KV, Babu JM, Kumar YR, Reddy SV, Kumar MK, Eswaraiah S, Reddy KR, Reddy MS, Bhaskar BV, Dubey PK, Vyas K. Impurity profile study of loratadine. J Pharm Biomed Anal. 2003 Apr 24;32(1):29-39. PubMed PMID: 12852446.

4: Zhong D, Blume H. [HPLC-determination of loratadine and its active metabolite descarboethoxyloratadine in human plasma]. Pharmazie. 1994 Oct;49(10):736-9. German. PubMed PMID: 7816900.

5: Squella JA, Sturm JC, Diaz MA, Pessoa H, Nuñez-Vergara LJ. Polarographic determination of loratadine in pharmaceutical preparations. Talanta. 1996 Dec;43(12):2029-35. PubMed PMID: 18966694.

6: Bhatt PM, Desiraju GR. Form I of desloratadine, a tricyclic antihistamine. Acta Crystallogr C. 2006 Jun;62(Pt 6):o362-3. Epub 2006 May 31. PubMed PMID: 16763328.

7: El-Enany N, El-Sherbiny D, Belal F. Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma. Chem Pharm Bull (Tokyo). 2007 Dec;55(12):1662-70. PubMed PMID: 18057737.

8: Anthes JC, Gilchrest H, Richard C, Eckel S, Hesk D, West RE Jr, Williams SM, Greenfeder S, Billah M, Kreutner W, Egan RE. Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor. Eur J Pharmacol. 2002 Aug 9;449(3):229-37. PubMed PMID: 12167464.

9: Villani FJ, Magatti CV, Vashi DB, Wong J, Popper TL. N-substituted 11-(4-piperidylene)-5,6-dihydro-11H-benzo-[5,6]cyclohepta [1,2-b]pyridines. Antihistamines with no sedating liability. Arzneimittelforschung. 1986 Sep;36(9):1311-4. PubMed PMID: 2947582.

10: Kaminski JJ, Carruthers NI, Wong SC, Chan TM, Billah MM, Tozzi S, McPhail AT. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine. Bioorg Med Chem. 1999 Jul;7(7):1413-23. PubMed PMID: 10465415.

11: Barnett A, Iorio LC, Kreutner W, Tozzi S, Ahn HS, Gulbenkian A. Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine. Agents Actions. 1984 Jun;14(5-6):590-7. PubMed PMID: 6236679.

12: Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther. 1997 Jan;280(1):114-21. PubMed PMID: 8996188.